Antimicrobial Activity of Quinazolin Derivatives of 1,2-Di(quinazolin-4-yl)‎diselane against Mycobacteria

Abstract EN

Mycobacterium tuberculosis (M.

tuberculosis) is one of the leading causes of morbidity and mortality.

Currently, the emergence of drug resistance has an urgent need for new drugs.

In previous study, we found that 1,2-di(quinazolin-4-yl)diselane (DQYD), a quinazoline derivative, has anticancer activities against many cancers.

However, whether DQYD has the activity of antimycobacterium is still little known.

Here our results show that DQYD has a similar value of the minimum inhibitory concentration with clinical drugs against mycobacteria and also has the ability of bacteriostatic activity with dose-dependent and time-dependent manner.

Furthermore, the activities of DQYD against M.

tuberculosis are associated with intracellular ATP homeostasis.

Meanwhile, mycobacterium DNA damage level was increased after DQYD treatment.

But there was no correlation between survival of mycobacteria in the presence of DQYD and intercellular reactive oxygen species.

This study enlightens the possible benefits of quinazoline derivatives as potential antimycobacterium compounds and furtherly suggests a new strategy to develop new methods for searching antituberculosis drugs.